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ABSTRACT
Introduction Concussion is a clinical diagnosis, based 
on self- reported patient symptoms supported by clinical 
assessments across many domains including postural 
control, ocular/vestibular dysfunction, and neurocognition. 
Concussion incidence may be rising in motorsport 
which, combined with unresolved challenges to accurate 
diagnosis and lack of guidance on the optimal return- 
to- race timeframe, creates a difficult environment for 
healthcare practitioners.
Methods and analysis Research Evaluating Sports 
ConcUssion Events—Rapid Assessment of Concussion 
and Evidence for Return (RESCUE- RACER) evaluates 
motorsports competitors at baseline (Competitor 
Assessment at Baseline; Ocular, Neuroscientific (CArBON) 
study) and post- injury (Concussion Assessment and Return 
to motorSport (CARS) study), including longitudinal data. 
CArBON collects pre- injury neuroscientific data; CARS 
repeats the CArBON battery sequentially during recovery 
for competitors involved in a potentially concussive event. 
As its primary outcome, RESCUE- RACER will develop the 
evidence base for an accurate trackside diagnostic tool. 
Baseline objective clinical scoring (Sport Concussion 
Assessment Tool—5th edition (SCAT5)) and neurocognitive 
data (Immediate Post- Concussion Assessment and 
Cognitive Testing (ImPACT)) will be assessed for specificity 
to motorsport and relationship to existing examinations. 
Changes to SCAT5 and ocular, vestibular, and reaction 
time function (Dx 100) will be estimated by the reliability 
change index as a practical tool for trackside diagnosis. 
Neuropsychological (Cambridge Neuropsychological Test 
Automated Battery (CANTAB)) assessments, brain MRI (7 
Tesla) and salivary biomarkers will be compared with the 
new tool to establish utility in diagnosing and monitoring 
concussive injuries.
Ethics and dissemination Ethical approval was 
received from East of England- Cambridge Central 
Research Ethics Committee (18/EE/0141). Participants 
will be notified of study outcomes via publications 
(to administrators) and summary reports (funder 
communications). Ideally, all publications will be open 
access.
Trial registration number February 2019 nationally 
(Central Portfolio Management System 38259) and 
internationally ( ClinicalTrials. gov NCT03844282).
INTRODUCTION
Concussion is defined by the Concussion 
In Sport Group as: ‘a traumatic brain injury 
induced by biomechanical forces’1 and is 
diagnosed clinically according to a constel-
lation of symptoms including alterations of 
mental state and consciousness.2 The natural 
history is believed to be benign, but there 
is significant individual heterogeneity in 
its severity and rate of recovery, with longer 
recovery periods in certain demographics, 
such as adolescents.3
Amidst rising concern about concussion in 
contact sports,4–7 there is scarce evidence in the 
scientific literature on the incidence, severity, 
and recovery of head injuries specifically in 
motorsport.8 What little there is suggests 
that even though there has been significant 
investment in safety, drivers continue to expe-
rience a greater risk of concussion compared 
with other high- risk sports.9 Furthermore, 
a recent survey in the international journal 
of motorsport medicine, AUTO+Medical, 
found that 70% of competitors: ‘did not feel 
completely normal’ when they attempted to 
return- to- race following concussion.10 This 
landscape in the motorsport environment 
specifically—a relatively high concussion inci-
dence combined with competitors returning 
before they have fully recovered—may leave 
competitors in control of a high- speed vehicle 
that poses an ongoing threat to the indi-
vidual, other participants, and the public. 
Accurate identification of concussion and a 
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return- to- race decision supported by scientific evidence 
is therefore of vital importance in reducing the poten-
tial morbidity and mortality associated with concussion 
in motorsport.
Despite the importance of brain injury in motorsport, 
there exists only a small body of formal motorsport guid-
ance for medical practitioners—resources which are 
often inconsistent and lack a scientific basis. The current 
mainstay of concussion assessment is a single clinical 
review reliant on self- reported patient symptoms, which 
are known to exhibit significant individual heteroge-
neity and to be variable in intensity over time. In areas of 
motorsport supported by a regular medical team, various 
assessment tools are used to assist with the return- to- race 
decision. Commonly, these tools are truncated versions 
of extended neurocognitive assessments which are most 
often used in the outpatient clinic, such as the Imme-
diate Post- Concussion Assessment and Cognitive Testing 
(ImPACT11). ImPACT can provide objective data to inter-
rogate specific deficits in memory, attention and fine 
motor skills, but can take up to 45 min to complete. A 
baseline assessment is advised, so that post- injury outputs 
can be directly compared with an individual’s previous 
results. Although ImPACT has been used at varying levels 
of motorsport competition worldwide since the early 
2000's, to date there has been no formal validation of 
its use for four- wheeled motorsport competitors specif-
ically,9 with only a single published study in motocross 
which does not include post- injury data.12 In motorsport 
therefore, as in other high- risk sports, there is a growing 
need for an objective, rapid and accurate diagnostic tool 
for concussion, validated with sport- specific data.
Outside of current clinical practice in motorsport, there 
is an enlarging literature exploring the use of neuropsy-
chological assessments applied to mild traumatic brain 
injury (mTBI) and concussion, with a recent focus on 
sports- related injuries. These assessments have become 
commonplace in the wider multidisciplinary clinical 
assessment of concussion in the outpatient setting and 
include examination of attention, working and long- term 
memory, social cognition, and awareness.13 Recently, the 
detection of more subtle perturbations to neuropsycho-
logical function have been increased with the use of 
computerised testing platforms. However, the majority of 
these assessments are conducted within the acute post- 
injury period (largely 7–10 days after injury) and there 
remains some controversy regarding their timing and 
the lack of a proven relationship between other objective 
measures of concussive injury.14 As a result, these instru-
ments continue to have low positive predictive value and 
their sensitivity is variable, even when combined with 
neurocognitive testing.15–19 Promisingly however, recent 
research has shown that the utility of these neuropsycho-
logical assessments can be augmented by exploration 
of executive function,20 combined with test platforms 
designed for high- functioning participants, such as 
the Cambridge Neuropsychological Test Automated 
Battery (CANTAB; www. camcog. com). In addition, 
formal neuropsychological re- evaluation throughout the 
recovery period has demonstrated potential to assist with 
rehabilitation from concussive injuries.21
From the comprehensive assessment batteries utilised 
in clinic during the recovery period, ‘sideline’ screening 
tests distill the most pertinent features to support clin-
ical decision- making on whether competitors are fit to 
resume participation acutely. These sideline concussion 
assessments offer a shorter alternative to outpatient 
clinic- based tools but remain relatively time consuming 
and can require specialist training. In addition, there 
is significant reliance on self- reported patient symp-
toms—a factor which is complicated by acknowledged 
under- reporting of concussion in motorsport specifically, 
a situation common in other sports.22–24 Despite these 
potential difficulties, there are numerous tools available 
for rapid assessment. The Sport Concussion Assessment 
Tool (SCAT), now in its fifth version, is freely available 
for clinical use in both adult25 and paediatric popu-
lations26 and has recently been added to motorsport 
concussion management protocols in the UK (personal 
communication: Dr Paul Trafford, 2018). This develop-
ment is encouraging, but as with the return- to- race tools 
described above, to date there has been no sport- specific 
validation of the SCAT5 relevant to motorsport, and thus 
its diagnostic utility in this setting remains formally unex-
plored.
An alternative but potentially rapid method of concus-
sion assessment is analysis of brain injury biomarkers. 
Studies investigating biomarker levels in cerebrospinal 
fluid and blood have demonstrated validity in mTBI and 
concussion (Refs. 27 28 and 29–33, respectively), but 
their sampling is invasive and therefore impractical in 
the sporting environment. However, the recent discovery 
of the glymphatic system,34 a waste clearance network for 
the central nervous system (CNS), provides a theoretical 
basis for the appearance of brain injury markers in a far 
more accessible body fluid—saliva. Indeed, there is a 
growing body of literature exploring the direct correla-
tion between traditional protein biomarkers of brain 
injury and saliva35; however, a more promising avenue 
may be analysis of microRNA (miRNA). MiRNAs are 
noncoding molecules essential for transcriptional regu-
lation and are detectable in a variety of body fluids, are 
stable in a variety of pH and are resistant to degradation 
by enzymes.36 Studies have demonstrated potential for 
both diagnostic and prognostic use of their measure-
ment in saliva for sports- related concussion in adolescent 
and adult populations, with recent work finding levels 
persisting for some weeks after the concussive event.37
In the absence of trackside testing facilities for 
biomarkers in the short term, attention has shifted to 
alternative methods of obtaining objective concussion 
assessment data. Historically, rapid clinical concussion 
assessments have relied on examination of the nervous 
system, based on the knowledge that neurosensory and 
balance- related effects are prevalent sequelae of brain 
injury.38 By extension, an accurate concussion diagnosis 
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may theoretically be obtained by examination of opto-
kinetic and vestibular reflexes, a method successful in 
discriminating concussed from control subjects with 
89% sensitivity and 95% specificity using a static neuro- 
otologic test centre.39 Technological advances mean 
that this signature of concussion can be captured in less 
than 10 minutes using a portable head- mounted display 
and eye- tracking system (certified as a Nonsignificant 
Risk Device by the Food and Drug Administration, and 
approved for clinical use—Regulation Number: 21 CFR 
882.1460). The Neurolign Dx 100 device captures objec-
tive data relevant to ocular, vestibular, and reaction time 
(OVRT) function. It has been applied informally to 
motorsport populations since 2017, with a small North 
American dataset showing promise for the identification 
of concussion,40 supported by a civilian cohort demon-
strating improvement in OVRT assessment measures 
throughout the acute recovery period.41 However, further 
motorsport- specific investigation is required to confirm 
the utility of Dx100 in the identification of concussion 
in this environment, in addition to its ability to monitor 
recovery acutely and therefore to assist with the return- 
to- race decision.
Despite encouraging advances in concussion assess-
ment modalities and technologies, there remains 
uncertainty regarding the underlying neuroscientific 
basis of this type of brain injury. Many scientists and 
clinicians believe that the clinical picture is under-
pinned by cell membrane disturbance with impairment 
in neurotransmitter signalling within the CNS, but 
without permanent cellular injury.42 There is poten-
tial to explore these disturbances with various forms of 
neuroimaging—a field which includes a wide range of 
technologies and data processing techniques capable of 
fundamentally changing our view of brain function in 
health, and after injury. MRI at 3 Tesla (T) can depict a 
wide range of phenomenon in the brain including struc-
tural changes, oedema, and haemorrhage, achieving 
resolutions of approximately 1 mm. More advanced MRI 
systems with static higher field strengths, such as 7 T, can 
reduce these resolutions to as low as 100 µm. In addi-
tion, it is possible to observe the blood oxygenation level 
dependent (BOLD) signal from the brain which varies in 
response to neuronal activity—the physical basis of func-
tional MRI (fMRI). Using fMRI, the organising principles 
of brain function are now considered to be communica-
tions between regions rather than solely activity within 
the regions.43 However, little is known about how the 
instruments described above as used in sports concus-
sion assessment relate to the structural and functional 
neurobiological changes that may occur in the brain as 
a result of concussion.44 Also untested is how neuroim-
aging might assist in the prediction of the time course for 
recovery after injury, and thus assist with the return- to- 
race decision in motorsport specifically.
The return- to- race decision is one of the most conten-
tious issues in modern motorsport medicine, yet there 
is a paucity of scientific evidence available to clinicians. 
There are no formal studies exploring the decision in 
motorsport specifically; however, a small extant litera-
ture from road use suggests that both task and driving 
performance are reduced in the short- to- medium term 
following concussion.45 46 Subsequent work advises that 
patients with concussion should not drive on the road 
for at least 24 hours after injury,47 although this period of 
avoidance is suggested without strong evidence and later 
timelines are not explored. More broadly, current return 
to road driving guidance produced for medical profes-
sionals in the UK is provided by the Driver and Vehicle 
Licensing Agency (DVLA); however, concussion is not 
specifically addressed in the most recent document.48 
As regards to UK governance of motorsport activity, the 
national sporting body Motorsport UK published their 
first Concussion Guidelines in early 2016 which advised 
removing drivers from competitive racing activity for 
14–21 days following a diagnosis of concussion.49 This 
approach is mirrored by limited international guidance50; 
however, there are no published guidelines from the 
worldwide governing body for four- wheeled motorsport, 
the Federation Internationale de l’Automobile (FIA).
In summary, sports- related concussion represents a 
growing public health issue worldwide that is reflected 
in motorsport. The naturally highly engineered, highly 
monitored environment of this sport specifically provides 
a unique opportunity to interrogate the causative forces 
of concussion and its neuroscientific effects over time. 
Research Evaluating Sports ConcUssion Events—Rapid 
Assessment of Concussion and Evidence for Return 
(RESCUE- RACER) seeks to address the issues of diagnosis 
and return to race. It is composed of two studies evalu-
ating motorsport competitors at baseline (CArBON) and 
post- injury (CARS), acquiring longitudinal data from 
the same participants where possible. Its primary objec-
tive is to contribute to the validation of promising rapid 
and objective diagnostic tools for concussion, providing 
data to assist clinicians with the safe removal of injured 
athletes from sports participation. It is also designed to 
establish the timeline to recovery after concussion asso-
ciated with motorsport, creating an evidence base for 
the return- to- race decision. The potential lessons learnt 
from this programme may be applicable to the field of 
general sports concussion, in addition to the assessment 
and management of similar brain injuries sustained on 
the road.
METHODS AND ANALYSIS
The RESCUE- RACER programme is composed of two, 
mixed cross- sectional and longitudinal, observational, 
non- interventional studies of motorsport competitors 
aged at least 16 years. In the baseline study, Compet-
itor Assessment at Baseline; Ocular, Neuroscientific 
(CArBON), healthy motorsport competitors will be 
recruited pre- injury to undertake clinical, neuropsy-
chological, neurocognitive, biomarker, and OVRT 
assessments, in addition to brain MRI, as normative 
distributions for the post- injury study. CArBON will 
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create a sample- specific neuroscientific characterisation 
and act as a baseline for post- concussion follow- up. The 
post- injury study, Concussion Assessment and Return to 
motorSport (CARS), will recruit motorsport competitors 
exposed to a potentially concussive event, or diagnosed 
with concussion, during motorsport activity. The battery 
of assessments used in CArBON will be reapplied to 
follow CARS participants in the recovery phase of their 
injury. CARS participants need not have been previously 
enrolled into CArBON, although CArBON participants 
who are subsequently diagnosed with concussion can 
provide longitudinal data in CARS.
The overall objective of RESCUE- RACER is to estab-
lish the natural history of clinical symptoms and signs, 
neurocognitive, neuropsychological, and OVRT function 
and brain injury biomarker levels following concussion 
sustained in motorsport activity. MRI data will charac-
terise the concussive injuries as a standard against which 
clinic assessments can be validated for sensitivity and 
specificity. The primary objective is to develop a track-
side diagnostic tool for concussion comparing the utility 
of SCAT5 against assessment of OVRT function, quanti-
fying severity immediately following injury and through 
recuperation during the acute recovery period. These 
data will form an evidence base for medical motorsport 
decision- making trackside, in addition to outpatient 
clinic management of potentially concussed competitors 
and completion of the return- to- race decision.
The RESCUE- RACER programme is being conducted 
over 2 years and aims to recruit n=50 participants into 
CArBON and n=70 participants into CARS. Partici-
pants may be enrolled in both studies. Written informed 
consent is obtained from adult participants, or from both 
the participant and parent/legal guardian for partici-
pants aged 16–18 years, in line with usual motorsport 
policy. Non- identifiable study data will be collected and 
managed using Research Electronic Data Capture tools 
hosted at University of Cambridge.51 52
Baseline study: CArBON
Inclusion and exclusion criteria for CArBON are outlined 
in table 1.
Sample selection: CArBON
Participants enrolled in the CArBON study are identified 
either by the Race Medical Director of the TOCA series 
(Touring Car Association; a UK- based motorsports event 
package registered as a Participant Identification Centre, 
PIC), or by the Team Principle of Aston Martin Racing 
(AMR, also registered as a PIC). The TOCA package 
consists of a number of semi- professional and professional 
competitive racing championships or series: three adult 
(British Touring Car Championship, Porsche Carrera 
Cup Great Britain, Michelin Ginetta GT4 Supercup); one 
mixed age group (Renault UK Clio Cup (replaced with 
the Mini Challenge in 2020), for drivers aged 17 years 
and over) and two adolescent (Simpson Race Products 
Ginetta Junior Championships, British Formula 4 Cham-
pionship, for drivers aged 14 and above). Recruitment 
presentations are delivered by the Study Coordinator at 
TOCA events and AMR training days to potential partic-
ipants, open to team managers, officials, race team staff, 
and competitors’ relatives. Potential participants can 
provide their contact details at these events or use the 
study website ( www. rescueracer. org) to contact the Study 
Team directly.
Assessments: CArBON
Assessments are made at one appointment which may 
take place across more than one session, at the partic-
ipant’s convenience. Full details of the assessments 
and their outcomes are in table 2. Demographic data 
include a minimum of age, sex, handedness, years of 
education, and years of motorsport experience. Partic-
ipants complete a standard 10 minute paper- based 
sideline clinical assessment tool, the SCAT525 and the 
ImPACT11—a computerised neurocognitive test lasting 
for up to 45 minutes. These tests are part of the usual 
baseline or pre- season concussion assessment in motor-
sport. Assessment of OVRT function is completed with a 
3D head- mounted display (Neurolign Dx100, previously 
known as I- Portal Portable Assessment System Nystagmo-
graph, or I- PAS) which includes a combination of ocular, 
vestibular, auditory, and reaction time tests. An MRI scan 
is acquired at the Wolfson Brain Imaging Centre, Univer-
sity of Cambridge on a Siemens Magnetom 7T Terra 
scanner or the Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses 3 T, where 7 T is contraindi-
cated. The scan protocol includes:
 ► T1- weighted MP2RAGE53 scan, to depict brain 
anatomy with scan parameters: repetition time 
Table 1 Baseline study (carbon) eligibility criteria





Mental capacity to consent 
to study participation.
Age <16 years.
Ongoing injuries so severe as to preclude study enrolment.
Recent (within the last 4 months) or current involvement in a research study 
involving administration of trial medication.
For MRI only: metal implants or exposure to metal foreign objects (such as 
welding), claustrophobia.
Prior severe or moderate traumatic brain injury, diagnosis of mild traumatic 
brain injury or concussion within the last 6 months, symptoms of head injury at 
time of enrolment.
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Table 2 Research Evaluating Sports ConcUssion Events—Rapid Assessment of Concussion and Evidence for Return 
assessments and their outputs
Assessment Summary of data collected
Demographic 
assessment
Data collected within the clinical review:
 ► Participant demographics and medical history
Name, address, date of birth, National Health Service number with MRN (local hospital identifier—where 
available), mobile number, up to two next of kin details (name, relationship, contact number), postal address, 
email address, general practitioner name and address, local hospital, medical and surgical history, current 
medications, allergies, family history, previous concussion assessments (type, number, date), time and date 
of last caffeine intake, the time from which the participant is advised to consume water only, if female—date 
of last menstrual period
 ► Motorsport history
Current level of competition, highest level of motorsport, years at current level, total number of years in 
motorsport competition of any type, current competition car and class, use of: helmet, head and neck 
support or hybrid device; type of seat
 ► Concussion history
Number of previous concussions and for each: date, setting, presence of loss of consciousness (LOC) 
and duration, confusion, retro/antero- grade amnesia (presence and duration), medical review, imaging, 
concussion assessment, time away from sport, referring hospital, length of admission, contact for medical 
information; estimated number of head injuries not formally diagnosed as concussion
 
From ImPACT:
 ► Participant demographics and educational history
Native country, native language, second language, completed years of education, previous completion of: 
speech therapy or special education classes, repetition of one or more school years, diagnosis of a learning 
disability, problems with attention deficit disorder (ADD) or hyperactivity
 ► Sporting history
Current sport, level of participation, primary competitive event, years at this level
 ► Concussion history
Number of concussions and for each presence of LOC, confusion, retrograde or anterograde amnesia; total 
number of sporting events missed due to concussion
 ► Potential confounding factors
Treatment for: headaches, migraines, epilepsy or seizures, substance/alcohol abuse, psychiatric conditions 
(such as depression, anxiety); previous brain surgery or meningitis, diagnoses of: ADD or attention- deficit 
hyperactivity disorder (ADHD), dyslexia, autism; strenuous exercise in the last 3 hours, hours of sleep the 
night prior to testing, current medications.
From CANTAB: age at assessment, handedness
From MRI: current weight (kg) and height (cm), previous operations, presence of metal implants, previous 
brain injury or LOC
Sport Concussion 
Assessment Tool 5
 ► Symptoms—number (range 0–22) and severity (rated as 0–6), summed to form a symptom severity score 
(range 0–132), with higher scores indicating worse symptoms
 ► Orientation score (out of 5)
 ► Immediate memory score (out of 30)
 ► Concentration score (out of 5)
 ► Neurological examination (normal/abnormal)
 ► Number of balance errors (out of 30)







Composite and raw scores assessing:
 ► Attention (including processing)
 ► Memory (verbal and visual recognition (%); visual working)
 ► Visual motor speed
 ► Impulse control (response inhibition)
 ► Delayed memory (delayed repetition of verbal and visual memory tasks, %)
Neurolign Dx100
(Dx100)
 ► Ocular tests—saccades (vertical, horizontal, predictive, self- paced, memory- guided and anti-), smooth 
pursuit, optokinetic reflex, vergence, light reflex
 ► Vestibular tests—subjective visual vertical
 ► Reaction time assessments—auditory, visual
Continued
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(TR)=4300 ms; echo time (TE)=1.99 ms; flip angle 
(FA) = 5o and 6o; voxel size: 0.75×0.75 × 0.75 mm³; a 
T2- weighted scan acquired with parameters: TR=8000 
ms; TE=68 ms; FA = 130o voxel size=0.2×0.2 ×3mm³ 
and a fluid- attenuated inversion recovery acquisition: 
inversion time (TI)=2400 ms; TR=9000 ms; TE=467 
ms; voxel size: 1.0×1.0 × 1.0 mm³.
 ► Susceptibility weighted imaging, sensitive to suscepti-
bility variations caused by venous blood and haemor-
rhages, is acquired with multi- echo scan parameters: 
TR=30 ms; TE1=4.57 ms, TE2=7.92 ms, TE3=11.27 
ms, TE4=14.62 ms, TE5=17.97 ms, TE6=21.32 ms; FA 
= 15o; voxel size=0.6 × 0.6 × 0.7 mm³.
 ► Diffusion weighted imaging, sensitive to motion of 
water, is acquired with scan parameters: TR=7240 m; 
TE1=56 ms TE2=84 ms; b- values=0 s/mm2 and 1000 s/
mm2; 20 directions; voxel size=1.4 × 1.4 × 1.4 mm³.
 ► fMRI, sensitive to BOLD contrast, is acquired with 
TR=1713 ms; TE=20 ms; FA = 60o; Voxel size=1.4 × 1.4 
× 1.4 mm³; 700 volumes.
Neuropsychological assessments are completed 
using the CANTAB touchscreen battery ( www. camcog. 
com), using a study- specific protocol which includes 
the following tasks: spatial working memory (assessing 
working memory and strategy), reaction time (assessing 
processing and psychomotor speed), paired associates 
learning and the multi- tasking test. After an oral rinse 
with tap water participants provide a saliva sample in 
sterile containers.
Where possible, all CArBON assessments will take 
place on the Addenbrooke’s Hospital site, to provide a 
comparable testing environment to the post- injury assess-
ments for CARS. To explore the effects of collecting data 
in a motorsport environment (which will be necessary for 
data collected in the immediate post- injury period as part 
of the CARS study), a subset of CArBON participants will 
complete portable assessments from the baseline battery 
at venues for motorsport competition.
Post-injury study: CARS
Inclusion criteria: CARS
Exposure to a potentially concussive event during 
motorsport activity or a diagnosis of concussion made 
by an experienced clinician less than 3 weeks prior to 
referral. Aside from history of previous brain injury, all 
other inclusion and exclusion criteria are identical to 
those for CArBON (table 1). To increase consistency 
in the diagnosis of concussion, referring clinicians will 
be encouraged to use the Motorsport UK Concussion 
Guidelines49 which will be presented, demonstrated, 
and discussed during educational events for motorsport 
medicine practitioners delivered prior to and during 
recruitment to CARS. Where available, the factors used 
by clinicians to make the diagnosis will also be recorded 
in the study database.
Sample selection: CARS
Most potential CARS participants are identified by the 
Race Medical Director for TOCA following involvement 
in a potentially concussive event during motorsport 
activity supported by TOCA. The Race Medical Director 
will make the initial approach to potential participants, 
where practicable, after serious injury is excluded by an 
independent medical practitioner. CARS participants 
may also be referred directly to the Chief Investigator.
Assessments: CARS
Portable study assessments (which include SCAT5, OVRT 
assessment, ImPACT, CANTAB, and saliva collection) 
can, where appropriate, be completed at race circuits 
immediately following the concussive injury and after 
completion of informed consent. Participants then 
attend the Sports Concussion Clinic at Addenbrooke’s 
Hospital, Cambridge and complete weekly assessments 
at 1, 2, and 3 weeks post- injury. This schedule will be 
independent of recovery from concussion, so that serial 
assessment data from CARS may be used as controls. 
Assessment Summary of data collected
Cambridge 
Neuropsychological 
Test Automated Battery 
(CANTAB)
The CANTAB study protocol includes a variety of assessments across attention (processing and 
psychomotor speed), memory (visual episodic), executive function and decision- making (working memory 
and strategy; planning).
Example tasks and their key outcome measures include:
 ► Spatial working memory (error, strategy)
 ► Reaction time (error scores, reaction, and movement times)
 ► Paired associates learning (error, number of trials to correctly locate patterns, stages completed)
 ► Multi- tasking test (performance during intermixed vs consistent rules and in/congruent information)
Saliva sample for 
biomarker analysis
To include, where possible, levels of:
 ► Neuronal injury such as neurofilament light chain (NFL)
 ► Glial injury such as S100B (a calcium- binding peptide)
 ► Epigenetic effects as measured by micro RNA levels (miRNA)
 ► Neurofibrillary degeneration as measured by tau
MRI of the brain  ► High- resolution T1- weighted structural imaging
 ► Susceptibility- weighted imaging
 ► Diffusion- weighted imaging
 ► Resting- state functional MRI
Table 2 Continued
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Should symptoms persist beyond this time, the partici-
pant is offered an additional two assessments at monthly 
intervals. All data collection methods mirror that of 
CArBON, including the MRI scanning protocols. In addi-
tion, participants can choose to provide consent for the 
Study Team to access one or more of: their motorsport 
records (medical notes, previous concussion assessments, 
and accident data) and medical notes (including contact 
with their general practitioner). Should this consent be 
provided, the Study Team are able to include additional 
data from the incident which may include: car telemetry, 
accident data recorder (ADR) outputs, in- ear accelerom-
eter (IEA) data, and incident footage (either in- car or 
from the circuit).
Sample size calculations
The proposed sample sizes for CArBON (n=50 compet-
itors assessed at baseline) and CARS (n=70 competitors 
involved in a potentially concussive event) are thought 
to be both feasible and sufficient to sample the wide 
heterogeneity of concussion in motorsport and to result 
in a clinically significant primary outcome. Where 
possible, repeated measures data from CArBON for 
those individuals later invited to participate in CARS will 
be longitudinal and form a qualitative narrative of the 
competitor’s neuroscientific profile as it evolves after 
involvement in a potentially concussive event.
Data analysis plan
The overall context of the study is to map the natural 
history of concussive symptoms and signs in motorsport 
immediately post- injury and throughout the recovery 
period. First, we will cross validate existing diagnostic 
tools using datasets collected in CArBON, then develop 
a new trackside diagnostic tool against which additional 
technologies can be validated.
Validation of existing diagnostic tests
Subject to appropriate ethical approvals, distributions 
of SCAT5 and ImPACT scores collected in CArBON 
(from non- concussed competitors) will be compared 
with samples collected from other sports participants 
(potential datasets include54 55 and,15 56–60 respectively) 
by comparison of central tendencies and qq- plotting 
to establish whether there is a need for sport- specific 
samples. The shared variance between SCAT5 and 
ImPACT total scores will be tested by correlation and an 
exploratory factor analysis will be undertaken across item 
scores. These tests will be used to characterise current 
concussion evaluation in motorsport following injury and 
during recovery.
Designing a trackside diagnostic tool
Practicalities limit the types of test that can be admin-
istered trackside or at other venues where motorsport 
incidents occur. Thus, a priori, SCAT5 and OVRT assess-
ments are the key measurements, together with history of 
concussive injuries, that will first be developed as a new 
diagnostic tool. This new tool is required to be both rapid 
and compact and therefore in the first instance dimen-
sion reduction will select components that explain at least 
80% of the variance from non- concussed (CArBON) data 
collected for each instrument. Test–retest reliabilities for 
these components will be estimated from longitudinal 
data, where available. CARS data from participants with 
clinically confirmed concussion will represent the true 
post- injury dataset. Individuals who have been exposed to 
a potentially concussive event, but who are not diagnosed 
with concussion will form a control cohort for these post- 
injury assessments.
The reliability change index (RCI61 62) will be calcu-
lated for each component for each individual subsequent 
to a potentially concussive brain injury and for whom 
longitudinal data are available from CARS. Statistical 
significance of the RCI is 1.96 (p<0.05). Clinical signif-
icance will be determined according to criteria outlined 
by Jacobson and Truax62: that the pre- to- post injury 
difference score (ie, CArBON to CARS) is greater than 
the RCI and that the recovered post- injury scores (CARS 
participants who have clinically recovered) fall within the 
range of normative values from CArBON. The clinical 
relevance of the chosen components will be verified by 
between- subject correlations of observed changes. These 
calculations will be made immediately post- injury and in 
the follow- up period.
As sample size and experience accumulates, guidelines 
for clinical use of the new test for diagnosis and return- 
to- race decisions will be updated and the empirical 
relationship between the number of components with 
statistical and clinical significance and their associated 
magnitudes of RCI to patient reports of symptom severity 
and unmeasured comorbidities.
Validation of new modalities to measure concussion
Exploratory investigations will take place to assess the 
relationships between MRI, CANTAB and saliva- derived 
biomarker levels to the SCAT5 and ImPACT non- 
concussed measures acquired in CArBON.
MRI
From T1- weighted structural MRI, voxelwise grey matter 
volume are estimated with FSL (https:// fsl. fmrib. ox. ac. 
uk/ fsl/ fslwiki/ FSLVBM). Cortical thickness is estimated 
using the Freesurfer package (https:// surfer. nmr. mgh. 
harvard. edu).
Functional MRI
Functional connectivity will be estimated between all 
brain regions, defined using a standard atlas, as correla-
tions of BOLD- sensitive fMRI signal acquired during 
rest in a graphical representation of nodes (regions) 
connected by weighted connections (edges): the func-
tional connectome.43 The connectome can then be 
characterised by graph theoretical parameters of local 
and global efficiency in the whole- brain connectome 
as well as seven large- scale networks related to specific 
cognitive domains.63
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Susceptibility weighted imaging
Following identification and removal of non- brain tissues 
from the image, the STI suite (10.1002/nbm.3056) will 
be used to undertake quantitative susceptibility mapping. 
This process computes tissue magnetic susceptibilities by 
first unwrapping the measured phase images and then 
removing contributions due to background susceptibil-
ities.
Cambridge Neuropsychological Test Automated Battery
Details of the tasks and outcome variables for neuropsy-
chological assessment are given in table 2. Post- injury 
neuropsychological assessment data from CARS will be 
compared with the motorsport- specific baseline (non- 
concussed) dataset collected during the CArBON study. 
Subject to appropriate ethical approvals, participants 
aged over 18 years may be compared with CANTAB’s own 
normative database (including up to 3000 adult healthy 
volunteers ideally matched for both gender and age), or 
from other relevant publications.64 Longitudinal anal-
ysis will be performed for participants enrolled in both 
CArBON and CARS, and for CARS participants with 
more than one study visit, in order to investigate acute 
and long- term alterations in neuropsychological func-
tion using a programme such as IBM SPSS Statistics or 
similar. In the first instance, this analysis will focus on key 
outcome measures identified in the CANTAB Connect 
Research Overview Document (see table 2). Thereafter, 
we will explore domains relevant specifically to the 
performance of motorsport competitors within each test 
variant (such as reaction and movement time responses).
Salivary biomarkers
Saliva samples will be analysed either in Cambridge or 
at collaborating UK institutions in order to explore a 
variety of potential biological mechanisms for concussion 
including: neuronal injury (measured by levels of neuro-
filament light chain, NFL), glial injury (for which a proxy 
measurement may be levels of S100B, a calcium- binding 
peptide), control of gene expression (as measured by 
levels of a panel of micro RNA, miRNA) and finally neuro-
fibrillary degeneration (as measured by levels of tau). 
Where appropriate, concentrations of these example 
potential biomarkers will be expressed as median and 
25th–75th percentiles. Statistically significant differences 
will be identified by standard group comparison statis-
tics (ie, the t- test for normally and the Mann- Whitney 
U two- sided test for non- normally distributed data). For 
comparison between proportions, Fisher’s exact test will 
be used. Statistical significance for all analyses will be 
p<0.05. The objective of these analyses is assessment of 
the strength of association between the miRNA panel or 
other brain injury biomarkers in concussed participants 
at the time of injury (CARS trackside) compared with 
competitors without concussion (CArBON), evaluated 
with Pearson correlations. Where possible non- concussed 
CARS participants will be compared with concussed 
CARS participants to explore the effects of an incident 
without brain injury. Pearson correlations will also be 
used to interrogate the saliva sample analysis to explore 
the kinetics of these biomarkers in the post- injury 
cohort (CARS) serially throughout recovery (at weeks 
1–3) compared with competitors without concussion 
(CArBON) and competitors participating in motorsport 
but not involved in an incident (CArBON). Where data 
are available, similar statistical methods will be used to 
correlate salivary biomarker levels with demographic 
information, including the severity of concussion, as well 
as the type and duration of symptoms, and time taken to 
return to participation in motorsport.
Finally, correlations between post- injury SCAT5 and 
ImPACT scores (or ‘pre- injury and post- injury differ-
ences’) and each output variable in each domain 
described above (in addition to the corresponding 
principal components) will be estimated and ranked 
according to effect size.
Patient and public involvement
Prior to drafting the study protocol, an informal investiga-
tion into the acceptability and design of RESCUE- RACER 
and the plan for result dissemination was conducted 
with TOCA competitors (2016 and 2017 seasons). Clin-
ical encounters were used as a platform for discussion 
(specifically attendance for baseline neurocognitive 
testing with the Study Coordinator). Approximately, 80 
drivers completed neurocognitive testing in 2016, with 
a large proportion successfully engaged in a short semi- 
structured discussion about RESCUE- RACER. In 2017, 
discussions outside of clinical encounters were conducted 
with a variety of motorsport personnel including team 
managers, championship administrators, Race Stewards, 
and Scrutineers, as well as members of the medical and 
rescue teams, in addition to relatives of drivers and guard-
ians/legal representatives of adolescent competitors. 
Review of the priorities, experiences and preferences 
from each of these stakeholder groups had a significant 
positive influence on the final protocol, allowing the 
recruitment strategy, assessments, their schedule, and 
the dissemination plan to be tailored to this specialised 
population. For example, tasks within the CANTAB and 
OVRT protocols were reordered to minimise partici-
pants’ frustration and reduce anxiety over time pressure, 
the latter often being a significant barrier to engagement 
with non- essential tasks within motorsport.
DISCUSSION
Although a common injury in sport, concussion remains 
both enigmatic and heterogenous in its mechanism, 
individual symptom profile, and subsequent resolution. 
Recent investigations are beginning to uncover the 
acute and chronic sequelae of concussive brain injuries 
in sports specifically, with directly observable conse-
quences to the way sports are medically managed and 
even played already evident worldwide. Within this land-
scape, motorsport offers a unique environment to study 
mild traumatic brain injuries, since at many levels of 
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the sport competitors are monitored prior to and even 
during the competitive season. When incidents occur, 
they are recorded in remarkable detail utilising a wealth 
of data sources including circuit footage, in- car engi-
neering data (commonly termed ‘telemetry’), and, where 
supported, IEA systems. In addition, many competitors 
now routinely also record their own competition footage 
with increasingly sophisticated in- car camera systems. 
Moreover, comprehensive medical assessment and treat-
ment is the first response to any incident in motorsport, 
with on- scene arrival times orders of magnitude quicker 
than usual responses to similar incidents on the road. 
This rapid- response, data- rich environment therefore 
provides a unique opportunity to correlate changes in 
clinical function to the causative forces associated with 
concussive brain injuries.
The potential and serious health, social, economic, 
and personal consequences of a concussive brain injury 
are universally acknowledged for the individual and 
society. Therefore, it is imperative in any sport that an 
accurate on- site diagnosis and assessment tool, in addi-
tion to a clear return- to- participation decision protocol, 
are supported by a credible clinical, neuroscientific, 
and psychological evidence base. This must be a priority 
across all sporting disciplines and motorsport is no 
exception. RESCUE- RACER addresses this unmet need 
for car racing in the first instance, but it is hoped that the 
lessons learnt will be applicable to other forms of motor-
sport, other sporting disciplines, and the roads alike. 
This novel research programme will collect high- quality 
clinical research data not only from the usual hospital 
environment, but also from an unusual prehospital 
setting. Collection of concussion assessment data from 
motorsport circuits specifically, acknowledged by the 
authors as a challenging and as yet unexplored environ-
ment, represents a real opportunity to bring academic 
clinical research into new real- world environments. The 
lessons learnt from the creation, support, and realisation 
of this research programme will be applicable to future 
research in similar environments relevant to clinicians 
working pitchside, trackside, and beyond.
In the first instance, the results of the RESCUE- RACER 
programme will be directly relevant to the diagnosis of 
concussion and return- to- race decisions in helmeted 
forms of two- wheeled motorsport including motorbike 
competition and motocross, where formal guidance 
is lacking. Beyond this, the results of this concussion 
in motorsport programme may be relevant to patients 
injured during road traffic collisions, especially road users 
travelling in motorised vehicles. Wider still, the dataset 
generated by RESCUE- RACER will also be relevant to the 
larger athletic community, publishing detailed baseline 
and post- injury data for the SCAT5. This freely available 
and rapid pitchside SCAT is currently used in almost all 
sporting disciplines; however, interpretation of its results 
is limited by a lack of publicly available data, especially 
with regards to thresholds for concussion identification. 
RESCUE- RACER will specifically address this unmet 
need. Outside of the sporting environment, the poten-
tial for rapid and accurate concussion assessment using 
technologies such as Dx100 will be relevant to the assess-
ment of concussion of any cause, in any medical setting. 
In particular, the creation of a rapid diagnostic protocol 
by the RESCUE- RACER programme has the potential to 
significantly expedite assessment in busy secondary care 
environments, with special relevance to time- pressured 
emergency departments. Finally, novel application of 
the computerised neuropsychological battery CANTAB 
to a specific subset of patients with mTBI represents a 
potential opportunity to remotely monitor recovery and 
guide rehabilitation. If successful, this digital assessment 
tool will be particularly relevant to clinicians operating in 
the post- COVID19 era, where face- to- face assessments are 
not always logistically feasible.
Of course, development of a diagnostic and prognostic 
tool is not the end of this journey, but the beginning 
of an evolutionary process to improve its sensitivity and 
specificity in the light of new information. This study 
contributes to the start of that process, testing and 
ranking contemporary technologies in OVRT assess-
ment, brain imaging, neuropsychology, and analysis of 
salivary markers relevant to brain injury, inflammation 
and potentially neurodegeneration. These approaches, 
and others, could be incorporated into future versions 
of the output diagnostic tool if practicalities permit but, 
in addition, they may also clarify the microscopic and 
macroscopic mechanisms that underlie the biological 
insult of a concussive injury and subsequently its sensory 
and behavioural sequelae.
While accurate diagnosis is key to subsequent clinical 
management of individual patients, the effectiveness of 
introducing new tools and protocols to the any sport 
requires long- term monitoring. Physical and neurocog-
nitive evaluations are currently a regular and mandatory 
component of participation in UK and most international 
motorsport; however, this is known to vary according to 
level of competition, venue, and country. In the coming 
seasons, we will collaborate with national and interna-
tional regulatory motorsport bodies to maintain records 
on changes in the number, severity and symptom profiles 
of concussive incidents experienced by motorsport 
competitors. Our overarching objectives are to improve 
the overall welfare of motorsport competitors in the near 
term as well as in the future, and to sustain this improve-
ment in the decades to come.
ETHICS AND DISSEMINATION
Prior to initiation of any assessments and for all studies, 
written informed consent is obtained from adult partic-
ipants, or from both the participant and parent/legal 
guardian for participants aged 16–18 years, in line with 
usual motorsport policy.
Participants will be notified of the programme outcomes 
via provision of relevant publications to the TOCA or 
AMR administrators and by inclusion of summary reports 
in Funder communications. Participants may specifically 
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request their individual results from the Chief Investi-
gator, which may be provided after publication of the 
overall study results.
Where possible, all publications will be in open access 
journals. There is a plan to make the study protocol freely 
available. There is no plan to make the full study report, 
anonymised participant level dataset or statistical code 
for result generation publicly available; however, these 
data can be shared on reasonable request.
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